News from the healthcare data industry
Real World Health Raises £1.37m To Help NHS Maximise Value of Data to Improve Patient Care LONDON, 12th June 2024 – Real World Health has closed a £1.37 million funding round to help the NHS make better use of its data and address critical challenges like surgery backlogs and mental health. The funding round…
CAMBRIDGE, Mass., June 10, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that Timothy (Tim) Albury has joined the company as Chief Financial Officer. “Tim has an outstanding track record in building value in businesses across healthcare and…
HealthVerity to offer AnalyticsIQ race and ethnicity data linked to over 2 million NPIs We are now able to provide insights into the race and ethnicity of approximately 85% of all healthcare providers in the nation’s largest healthcare data ecosystem.” — Andrew Kress, HealthVerity CEOPHILADELPHIA, PA, UNITED STATES, June 4,…
CAMBRIDGE, Mass., June 2, 2024 /PRNewswire/ — ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform. This collaboration leverages NVIDIA Inference microservices (NIM), including the recently published Llama 3 NIM,…
The Company is Also Forging Strategic Partnerships With Pharmaceutical Companies and Vertically Integrated Healthcare Companies to Drive Evidence Adoption in Oncology and other Specialty areas May 23, 2024 09:24 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence…
Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes CAMBRIDGE, Mass., May 31, 2024 /PRNewswire/ — ConcertAI, a leader in oncology predictive and generative AI SaaS and real-world data (RWD) solutions for healthcare and life sciences, today announces first-in-category predictive and…
May 22, 2024 09:00 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Today, COTA announced an extension of its research collaboration with the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence. Under the collaboration, the two organizations will continue to jointly develop and implement research projects to advance the use…
WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) — Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials. This new offering expands upon Syapse’s existing offering of Enriched Cohorts, and is designed to empower cancer researchers and life sciences companies with unparalleled insights…
The European Medicines Agency (EMA) is seeking feedback on non-interventional studies (NIS) that use real-world data (RWD) for regulatory purposes. In the draft reflection paper, EMA defines a NIS as a human study that does not fulfill any of the conditions defining a clinical trial. NIS collect data in normal…
The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient journey and further patient outcomes through prediction, precision, and discovery May 06, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM –…